Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case report

BACKGROUND: Triple-negative breast cancer (TNBC) is an aggressive cancer subtype, owing to its high metastatic potential: Patients who develop brain metastases (BMs) have a poor prognosis due to the lack of effective systemic treatments. Surgery and radiation therapy are valid options, while pharmac...

Descripción completa

Detalles Bibliográficos
Autores principales: di Mauro, Pierluigi, Schivardi, Greta, Pedersini, Rebecca, Laini, Lara, Esposito, Andrea, Amoroso, Vito, Laganà, Marta, Grisanti, Salvatore, Cosentini, Deborah, Berruti, Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987211/
https://www.ncbi.nlm.nih.gov/pubmed/36890829
http://dx.doi.org/10.3389/fonc.2023.1139372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987211/
https://www.ncbi.nlm.nih.gov/pubmed/36890829
http://dx.doi.org/10.3389/fonc.2023.1139372

Ejemplares similares